Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Diffusion Kurtosis Imaging Detects Microstructural Alterations in Brain of α-Synuclein Overexpressing Transgenic Mouse Model of Parkinson's Disease: A Pilot Study

A. Khairnar, P. Latta, E. Drazanova, J. Ruda-Kucerova, N. Szabó, A. Arab, B. Hutter-Paier, D. Havas, M. Windisch, A. Sulcova, Z. Starcuk, I. Rektorova,

. 2015 ; 28 (4) : 281-9. [pub] 20150708

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc16028379

Evidence suggests that accumulation and aggregation of α-synuclein contribute to the pathogenesis of Parkinson's disease (PD). The aim of this study was to evaluate whether diffusion kurtosis imaging (DKI) will provide a sensitive tool for differentiating between α-synuclein-overexpressing transgenic mouse model of PD (TNWT-61) and wild-type (WT) littermates. This experiment was designed as a proof-of-concept study and forms a part of a complex protocol and ongoing translational research. Nine-month-old TNWT-61 mice and age-matched WT littermates underwent behavioral tests to monitor motor impairment and MRI scanning using 9.4 Tesla system in vivo. Tract-based spatial statistics (TBSS) and the DKI protocol were used to compare the whole brain white matter of TNWT-61 and WT mice. In addition, region of interest (ROI) analysis was performed in gray matter regions such as substantia nigra, striatum, hippocampus, sensorimotor cortex, and thalamus known to show higher accumulation of α-synuclein. For the ROI analysis, both DKI (6 b-values) protocol and conventional (2 b-values) diffusion tensor imaging (cDTI) protocol were used. TNWT-61 mice showed significant impairment of motor coordination. With the DKI protocol, mean, axial, and radial kurtosis were found to be significantly elevated, whereas mean and radial diffusivity were decreased in the TNWT-61 group compared to that in the WT controls with both TBSS and ROI analysis. With the cDTI protocol, the ROI analysis showed decrease in all diffusivity parameters in TNWT-61 mice. The current study provides evidence that DKI by providing both kurtosis and diffusivity parameters gives unique information that is complementary to cDTI for in vivo detection of pathological changes that underlie PD-like symptomatology in TNWT-61 mouse model of PD. This result is a crucial step in search for a candidate diagnostic biomarker with translational potential and relevance for human studies.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16028379
003      
CZ-PrNML
005      
20161020122152.0
007      
ta
008      
161005s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12640-015-9537-9 $2 doi
024    7_
$a 10.1007/s12640-015-9537-9 $2 doi
035    __
$a (PubMed)26153486
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Khairnar, Amit $u Applied Neuroscience Research Group, CEITEC - Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
245    10
$a Diffusion Kurtosis Imaging Detects Microstructural Alterations in Brain of α-Synuclein Overexpressing Transgenic Mouse Model of Parkinson's Disease: A Pilot Study / $c A. Khairnar, P. Latta, E. Drazanova, J. Ruda-Kucerova, N. Szabó, A. Arab, B. Hutter-Paier, D. Havas, M. Windisch, A. Sulcova, Z. Starcuk, I. Rektorova,
520    9_
$a Evidence suggests that accumulation and aggregation of α-synuclein contribute to the pathogenesis of Parkinson's disease (PD). The aim of this study was to evaluate whether diffusion kurtosis imaging (DKI) will provide a sensitive tool for differentiating between α-synuclein-overexpressing transgenic mouse model of PD (TNWT-61) and wild-type (WT) littermates. This experiment was designed as a proof-of-concept study and forms a part of a complex protocol and ongoing translational research. Nine-month-old TNWT-61 mice and age-matched WT littermates underwent behavioral tests to monitor motor impairment and MRI scanning using 9.4 Tesla system in vivo. Tract-based spatial statistics (TBSS) and the DKI protocol were used to compare the whole brain white matter of TNWT-61 and WT mice. In addition, region of interest (ROI) analysis was performed in gray matter regions such as substantia nigra, striatum, hippocampus, sensorimotor cortex, and thalamus known to show higher accumulation of α-synuclein. For the ROI analysis, both DKI (6 b-values) protocol and conventional (2 b-values) diffusion tensor imaging (cDTI) protocol were used. TNWT-61 mice showed significant impairment of motor coordination. With the DKI protocol, mean, axial, and radial kurtosis were found to be significantly elevated, whereas mean and radial diffusivity were decreased in the TNWT-61 group compared to that in the WT controls with both TBSS and ROI analysis. With the cDTI protocol, the ROI analysis showed decrease in all diffusivity parameters in TNWT-61 mice. The current study provides evidence that DKI by providing both kurtosis and diffusivity parameters gives unique information that is complementary to cDTI for in vivo detection of pathological changes that underlie PD-like symptomatology in TNWT-61 mouse model of PD. This result is a crucial step in search for a candidate diagnostic biomarker with translational potential and relevance for human studies.
650    _2
$a zvířata $7 D000818
650    _2
$a mozek $x metabolismus $x patologie $7 D001921
650    _2
$a difuzní magnetická rezonance $x metody $7 D038524
650    _2
$a zobrazování difuzních tenzorů $x metody $7 D056324
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši transgenní $7 D008822
650    _2
$a pohybová aktivita $7 D009043
650    _2
$a Parkinsonova nemoc $x metabolismus $x patologie $7 D010300
650    _2
$a pilotní projekty $7 D010865
650    _2
$a alfa-synuklein $x metabolismus $7 D051844
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Latta, Peter $u Multimodal and Functional Imaging Laboratory, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
700    1_
$a Drazanova, Eva $u Institute of Scientific Instruments, Academy of Sciences of the Czech Republic, Brno, Czech Republic. Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Ruda-Kucerova, Jana $u Experimental and Applied Neuropsychopharmacology Group, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic. Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Szabó, Nikoletta $u Department of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Centre, University of Szeged, Szeged, Hungary.
700    1_
$a Arab, Anas $u Experimental and Applied Neuropsychopharmacology Group, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic. Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. $7 gn_A_00007913
700    1_
$a Hutter-Paier, Birgit $u QPS Austria GmbH, Grambach, Austria.
700    1_
$a Havas, Daniel $u QPS Austria GmbH, Grambach, Austria.
700    1_
$a Windisch, Manfred $u NeuroScios GmbH, Graz, Austria.
700    1_
$a Sulcova, Alexandra $u Experimental and Applied Neuropsychopharmacology Group, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
700    1_
$a Starcuk, Zenon $u Multimodal and Functional Imaging Laboratory, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic. Institute of Scientific Instruments, Academy of Sciences of the Czech Republic, Brno, Czech Republic.
700    1_
$a Rektorova, Irena $u Applied Neuroscience Research Group, CEITEC - Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. irena.rektorova@ceitec.muni.cz.
773    0_
$w MED00180457 $t Neurotoxicity research $x 1476-3524 $g Roč. 28, č. 4 (2015), s. 281-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26153486 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20161020122559 $b ABA008
999    __
$a ok $b bmc $g 1166693 $s 953009
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 28 $c 4 $d 281-9 $e 20150708 $i 1476-3524 $m Neurotoxicity research $n Neurotox Res $x MED00180457
LZP    __
$a Pubmed-20161005

Find record

Citation metrics

Archiving options